Interface Inc (TILE) · Nov 6, 2026 · Earnings
Miss — Adjusted EPS $0.68 vs ~$0.61 consensus; sales $366.7M vs ~$377.6M consensus
Interface earnings beat on adjusted EPS, yet Q3 revenue missed expectations and weaker Europe drove a lower 2026 sales outlook.
Interface is in the execution phase of its One Interface strategy: combining carpet tile, LVT, and rubber flooring, cross-selling across end markets, and using productivity and manufacturing improvements to expand margins. The prior quarter had raised full-year guidance on strong results and backlog, so this filing is a test of whether that momentum is holding.
The quarter was profitable but not demand-strong enough. Adjusted EPS of $0.68 exceeded the published consensus of roughly $0.61, but revenue of $366.7 million fell short of consensus near $377.6 million. The filing says certain Retail and nora deliveries shifted into future periods, but the miss still matters because currency-neutral orders rose only 0.8% overall and EAAA orders declined 6.8%.
| Metric | Q3 2026 | Q3 2025 | Consensus / Prior guide |
|---|---|---|---|
| Net sales (Consolidated Results Summary) | $366.7M (-) | $364.5M | ~$377.6M |
| Adjusted EPS (Consolidated Results Summary) | $0.68 (+11.5%) | $0.61 | ~$0.61 |
| Adjusted gross margin (Consolidated Results Summary) | 40.6% (+103 bps) | 39.5% | 40.8% Q3 guide |
| Adjusted operating income (Consolidated Results Summary) | $57.2M (+5.7%) | $54.1M | |
| FY26 net sales outlook (Full Fiscal Year 2026 Outlook) | $1.440B-$1.455B | $1.455B-$1.485B prior | |
| Net debt (Additional Metrics) | $49.1M (-55.4%) | $110.3M at FY25 end |
Margin execution was the clear positive. Adjusted gross margin expanded 103 basis points despite higher raw-material and tariff costs, while adjusted SG&A came in below the prior quarterly outlook. That allowed adjusted operating income and EPS to grow even though sales were essentially flat year over year. “Third quarter 2026 adjusted gross profit margin increased 103 basis points year-over-year as favorable pricing and product mix combined with manufacturing efficiencies were partially offset by higher raw material and tariff-related costs.” 〔0〕
The more important change is the lower revenue trajectory. Interface cut its FY26 sales range by $15 million at the midpoint, explicitly citing softer European conditions, while leaving its earnings outlook intact. That is not a collapse in the operating model, but it shifts the story from broad-based growth toward extracting more profit from slower volume. “Interface is reaffirming its full fiscal year earnings guidance on strong operational execution, while revising its full fiscal year net sales outlook to reflect softer conditions in Europe.” 〔1〕
The regional split makes the slowdown more specific. Americas orders increased 6.2%, while EAAA orders fell 6.8%; management also said Healthcare billings grew 5% after 29% growth a year earlier, with Education and Corporate Office only growing in the low single digits. That supports the One Interface strategy in the Americas, but shows Europe is no longer merely a currency issue—it is becoming a volume headwind. “Global billings grew across all three primary market segments, led by Healthcare, which increased 5% on top of 29% growth in the prior-year quarter, while Education and Corporate Office each grew in the low single digits,” 〔2〕
The balance sheet gives Interface room to manage through the softer demand. Net debt fell to $49.1 million from $110.3 million at year-end, and the net leverage ratio was only 0.2x adjusted EBITDA. That reduces financial pressure, but it does not offset the fact that the revenue outlook has moved lower while the company remains exposed to tariffs, raw materials, and European demand.
Bottom line: Interface is executing well on margins and debt reduction, but the sales miss and lower full-year revenue outlook weaken the growth story. The filing is a mixed quarter that leans negative because profitability is currently outrunning demand rather than being powered by it.
Q4 report and FY2027 outlook
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!